Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of AMRX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders153155+2
Shares99.4M99.6M+197.1K (+0.2%)
Value$316.0M$201.0M−$115.1M (−36.4%)

New holders (27)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to AMRX in Q3 2022
InstitutionSharesValue% of portfolio
OrbiMed Advisors LLC1,583,490$3.20M0.06%
Susquehanna Fundamental Investments, LLC173,608$351.0K0.01%
Connor, Clark & Lunn Investment Management Ltd.153,690$310.0K0.00%
Cornercap Investment Counsel Inc149,516$302.0K0.06%
Virginia Retirement Systems Et Al130,200$263.0K0.00%
SG Americas Securities, LLC62,243$126.0K0.00%
Jane Street Group, LLC56,299$114.0K0.00%
Jump Financial, LLC52,300$105.0K0.00%
Atria Wealth Solutions, Inc.37,200$75.1K0.00%
Occudo Quantitative Strategies LP35,998$73.0K0.01%
Schonfeld Strategic Advisors LLC32,352$65.0K0.00%
Man Group plc25,703$52.0K0.00%
Two Sigma Securities, LLC24,076$49.0K0.01%
Virtu Financial LLC21,605$44.0K0.00%
Ergoteles LLC17,759$36.0K0.00%
Price T Rowe Associates Inc17,091$35.0K0.00%
Gladius Capital Management LP16,596$34.0K0.01%
Toroso Investments, LLC10,540$21.0K0.00%
Point72 Hong Kong Ltd8,823$18.0K0.00%
Allworth Financial LP6,365$13.0K0.00%
CWM, LLC2,837$6.00K0.00%
TCI Wealth Advisors, Inc.2,680$5.00K0.00%
Brown Brothers Harriman & Co1,688$3.00K0.00%
Quadrant Capital Group LLC746$2.00K0.00%
Glassman Wealth Services325$1.00K0.00%
Parallel Advisors, LLC60$00.00%
SJS Investment Consulting Inc.4$00.00%

Sold out (25)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.